GPX4 and cancer: Similar to cancer cells undergoing ferroptosis [45], GPX4 protein instability in naïve ESCs after bME depletion (Fig. 5E) was restored by treatment with carfilzomib, a proteasome inhibitor [21] (Fig. 5F).